Research & Development

色哥哥-最新成人激情网一本道久久久999欧美最大色情网183部分省市银行业不良资产转让规模锐减百亿

發布時間︰

  地里的禾苗已經有一尺來高了,長得稀稀疏疏的,低窪的地方水足,麥苗就長得高些,高處的澆不上水,麥苗就長得發黃。   “如此,卓氏一月只可問我下等事一次!”色哥哥-最新成人激情网   難道是鮮肉也能弄出同樣的效果?一本道久久久999   “這是什麼肉?”   血參可以肥你卓氏,雲瑯若能收為心腹,他可保你一世平安。欧美最大色情网183   走門丟人,跳窗戶翻牆就是高門大戶的行徑?雲瑯根本就無法理解霍去病。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo